$CTSH

Dalal Jatin P sold $669K of CTSH

Dalal Jatin P (Chief Financial Officer) sold 12,000 shares of COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) at $55.76 ($0.67M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dalal Jatin P
Published Aug 5, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:29 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTSH
Neutral
high confidence
Mentioned
$CTSH
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSHNeutralLow
01

Why it matters

The newest fact is the CFO’s planned open-market sale size, price, and post-transaction holdings. This can marginally influence sentiment but does not constitute new company fundamentals.

02

Market read

Traders may note insider selling, but the 10b5-1 framing reduces the likelihood of a meaningful fundamental repricing.

03

What to watch

The article provides only the sale details; it does not include any offsetting insider buys, changes in other executives’ activity, or company-specific catalysts that would make the signal tradable.

Relevance 4/10Novelty 3/10Timing: Filed 2026-08-05, transaction dated 2026-08-03.

Background

The article is an SEC Form 4 insider transaction disclosure for Cognizant Technology Solutions (CTSH).

Company-level read

Ticker impact

$CTSHNeutralHigh confidence
Context

CFO Dalal Jatin P filed a Form 4 open-market sale of 12,000 CTSH shares at $55.7640 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited and short-lived.

Evidence & confidence

The filing is a routine 10b5-1 planned sale by the CFO, with no guidance, operational, or regulatory developments disclosed in the text.

Market effects

Minimal. Insider sale in a single large-cap IT services name does not materially reset sector expectations.

Minimal, US-focused filing with no stated cross-border operational impact.

Minimal, no global deal, regulation, or macro linkage described.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations, so any negative read-through could be overstated.

Key entities

  • CTSH

    Cognizant Technology Solutions Corp, the subject of the Form 4 insider transaction.

  • Dalal Jatin P

    Chief Financial Officer who sold 12,000 shares under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.